Progression-free survival (A) and overall survival (B) | Open-i
Factors associated with overall survival, progression-free survival and toxicity in patients with small cell lung cancer and thoracic irradiation in a clinical real-world setting | Radiation Oncology | Full Text
The frequency of assessment of progression in randomized oncology clinical trials - Haslam - 2022 - Cancer Reports - Wiley Online Library
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of
Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials - London - 2017 - Cancer - Wiley
Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis - Katrin M. Sjoquist, Sarah J. Lord, Michael L. Friedlander, Robert John Simes, Ian C. Marschner,
The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer | The Patient - Patient-Centered Outcomes Research
Progression free survival and overall survival in patients treated with... | Download Scientific Diagram
Overall survival vs disease-free survival and other surrogate endpoints - survival-analysis - Datamethods Discussion Forum
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Exploring the relationship between Overall Survival (OS), Progression Free Survival (PFS) and Objective Response Rate (ORR) in patients with advanced melanoma - ScienceDirect
Estimating progression-free survival in patients with glioblastoma using routinely collected data | Journal of Neuro-Oncology
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Real-World Progression-Free Survival as an Endpoint in Advanced Non-Small-Cell Lung Cancer: Replicating Atezolizumab and Docetaxel Arms of the OAK Trial Using Data Derived From Electronic Health Records | medRxiv
Recurrence/progression-free survival and overall survival among... | Download Scientific Diagram
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Progression-Free Survival Is a Surrogate for Survival in Advanced Colorectal Cancer | Journal of Clinical Oncology
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia
Progression-free survival (A) and overall survival of ( | Open-i